After 19 years, Dr Willem Remme has stepped down as Editor-in-Chief of the Journal Cardiovascular Drugs and Therapy. Upon reflection of the hundreds of papers which have crossed his desk, Dr Remme highlighted a selection of his top publications. (read editorial HERE)
The Hatter Cardiovascular Institute was honoured to be singled out as one of the most highly cited articles: NECROSTATIN, A POTENTIALLY CARDIOPROTECTIVE AGENT (DEREK YELLON, 200 CITES
Dr Remme commented on the many special publications of the journal and gave special attention to Prof Sean Davidson’s editorial: BUILDING A BRIDGE TO THE FUTURE OF CARDIOVASCULAR DRUGS AND THERAPY.
We wish to thank Dr Remme for all his hard work as Editor-in Chief of CDT and wish him all the best in his future endeavours.